Blood Vessel Growth Research Surges as Angiogenesis Science Reaches New Heights
Angiogenesis research is transforming cancer, eye disease, and regenerative medicine, and its leading journal's new impact factor underscores the field's ...
Angiogenesis research is transforming cancer, eye disease, and regenerative medicine, and its leading journal's new impact factor underscores the field's ...
Doctors in China report the first sequential use of efgartigimod and telitacicept to rescue a 73-year-old MuSK-myasthenia gravis patient from ...
A meta-analysis of 17 studies finds that Helicobacter pylori infection is associated with worse overall and progression-free survival in cancer ...
A new review in Medical Oncology argues that tumor ablation can act as an in situ vaccine whose systemic power ...
A large analysis of melanoma patients treated with immune checkpoint inhibitors finds that 12 percent develop significant neurotoxicity, often within ...
A new review maps the engineering strategies, from dual-target receptors to tumor microenvironment remodeling, that could finally bring CAR-T cell ...
A phase II trial found that preoperative chemo-immunotherapy with sintilimab achieved major pathological responses in 59.1 percent of locally advanced ...
A team at Nanjing Medical University used RFdiffusion to design a CLDN18.2-targeting T-cell engager for gastric cancer and showed that ...
A new study shows that a simple index combining hemoglobin and the albumin-to-alkaline phosphatase ratio can predict survival outcomes in ...
A new review maps how gut microbes and their metabolites bidirectionally shape T cell immunity to drive autoimmune, alcohol-associated, metabolic ...
A new review in Molecular Biology Reports maps how the ceramide–S1P balance and ganglioside signaling form a cancer-type-specific lipid code ...
Researchers combined anti-PD-L1 immunotherapy with the PARP inhibitor Olaparib to trigger ferroptosis in liver cancer and used the SLC7A11-targeted PET ...
A new Nature Aging study from Mass General Brigham shows that male and female immune systems age differently, with earlier ...
A paired genomic and transcriptomic study of 32 patients shows that EGFR-mutant lung adenocarcinoma transforms into an immunosuppressed yet immunologically ...
A comprehensive review finds that while artificial intelligence shows striking performance in detecting, staging, and predicting gastric cancer outcomes, most ...
The FDA has approved atezolizumab with chemotherapy for adjuvant treatment of stage III dMMR colon cancer after the phase III ...
A new review maps how inorganic nanoparticles, polymers, DNA nanostructures, and cell-derived vesicles are being engineered to actively reprogram the ...
A Mass General Brigham study of malignant ascites has identified rare RORC-expressing dendritic cells that may promote immune tolerance in ...
Researchers have discovered a clonally coordinated network of suppressive regulatory T cells that spans the blood, lymph nodes and airways ...
New research shows Pseudomonas aeruginosa reprograms protective Th17 cells into pathogenic interferon-gamma-producing effectors that directly damage the cystic fibrosis lung ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.